Combination Therapy with Hepatocyte Growth Factor and Oseltamivir Confers Enhanced Protection Against Influenza Viral Pneumonia

MLA

Narasaraju, T., et al. “Combination Therapy with Hepatocyte Growth Factor and Oseltamivir Confers Enhanced Protection Against Influenza Viral Pneumonia.” Current Molecular Medicine, vol. 14, no. 5, June 2014, pp. 690–702. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs33082983&authtype=sso&custid=ns315887.

APA

Narasaraju, T., Yang, E., Samy, R. P., Tan, K. S., Moorthy, A. N., Phoon, M. C., van Rooijen, N., Choi, H. W., & Chow, V. T. (2014). Combination Therapy with Hepatocyte Growth Factor and Oseltamivir Confers Enhanced Protection Against Influenza Viral Pneumonia. Current Molecular Medicine, 14(5), 690–702.

Chicago

Narasaraju, T., E. Yang, R.P. Samy, K.S. Tan, A.N. Moorthy, M.C. Phoon, N. van Rooijen, H.W. Choi, and V.T. Chow. 2014. “Combination Therapy with Hepatocyte Growth Factor and Oseltamivir Confers Enhanced Protection Against Influenza Viral Pneumonia.” Current Molecular Medicine 14 (5): 690–702. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs33082983&authtype=sso&custid=ns315887.